Back to search

Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.

Data up to Jan 2025

Published1999
Citations236
References39

Total Citations Per Year

Abstract

References (39)

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

Enzyme kinetics; behavior and analysis of rapid equilibrium and steady state enzyme systems

1994 • 3,007 citations

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

1994 • 2,716 citations

IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A

1998 • 826 citations

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*

1996 • 598 citations

Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.

1990 • 487 citations

Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver

1989 • 480 citations

Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.

1987 • 475 citations

Human liver carbamazepine metabolism

1994 • 428 citations

First-pass metabolism of cyclosporin by the gut

1991 • 425 citations

Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).

1990 • 402 citations

Cooperativity in Oxidations Catalyzed by Cytochrome P450 3A4

1997 • 380 citations

Interaction between grapefruit juice and midazolam in humans*

1995 • 360 citations

Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.

1994 • 350 citations

Disposition of intravenous and oral cyclosporine after administration with grapefruit juice*

1995 • 349 citations

Activation of CYP3A4: Evidence for the Simultaneous Binding of Two Substrates in a Cytochrome P450 Active Site

1994 • 348 citations

Expression of Modified Human Cytochrome P450 3A4 in Escherichia coli and Purification and Reconstitution of the Enzyme

1993 • 341 citations

Cyclosporin Clinical Pharmacokinetics

1993 • 338 citations

Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction

1992 • 337 citations

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin

1996 • 280 citations

The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*

1995 • 275 citations

The pharmacokinetics of midazolam in man

1981 • 273 citations

Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.

1995 • 270 citations

Verapamil

1989 • 254 citations

The Kinetics of Aflatoxin B1Oxidation by Human cDNA-Expressed and Human Liver Microsomal Cytochromes P450 1A2 and 3A4

1996 • 247 citations

Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.

1994 • 221 citations

Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.

1996 • 191 citations

The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.

1996 • 173 citations

Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.

1996 • 157 citations

Expression of Cytochrome-P450-3A5 in Escherichia Coli: Effects of 5′ Modification, Purification, Spectral Characterization, Reconstitution Conditions, and Catalytic Activities

1995 • 141 citations

Roles of Divalent Metal Ions in Oxidations Catalyzed by Recombinant Cytochrome P450 3A4 and Replacement of NADPH-Cytochrome P450 Reductase with Other Flavoproteins, Ferredoxin, and Oxygen Surrogates

1995 • 128 citations

Role of phospholipids in reconstituted cytochrome P 450 3A form and mechanism of their activation of catalytic activity

1992 • 124 citations

Felodipine kinetics in healthy men

1985 • 114 citations

Detection of a CYP3A5 Allelic Variant: A Candidate for the Polymorphic Expression of the Protein?

1996 • 84 citations

cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.

1994 • 83 citations

Human Alfentanil Metabolism by Cytochrome P450 3A3/4. An Explanation for the Interindividual Variability in Alfentanil Clearance?

1993 • 70 citations

Population pharmacokinetics of terfenadine.

1996 • 26 citations

Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailability.

1996 • 24 citations

Volume 317, Number 2 (1995), in the article "Expression of Cytochrome P450-3A5 in Escherichia-Coli: Effects of 5′ Modification, Purification, Spectral Characterization, Reconstitution Conditions, and Catalytic Activities," by Elizabeth M. J. Gillam, Zuyu Guo, Yuane-Fang Ueng, Hiroshi Yamazaki, Ian Cock, Paul E. B. Reilly, Wage D. Hooper, and F. Peter Guengerich pp374-384

1995 • 15 citations

Cited By (0)

No citing papers found in database

Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes:… (1999) – PubMed | Metascience Observatory Explorer